Anthenoside A

N-[(2R,3S,5R)-2-[[(3S,5S,6S,7R,9R,10R,13R,16R,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-16-yl]oxy]-4-hydroxy-6-(hydroxymethyl)-5-methoxyoxan-3-yl]acetamide

RNKLRQYEPYNQHD-NSMQWETHSA-N CHEBI:183128 0 Reactome links 2 studies
2 Observed studies
2 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
RNKLRQYEPYNQHD-NSMQWETHSA-N
IUPAC name
N-[(2R,3S,5R)-2-[[(3S,5S,6S,7R,9R,10R,13R,16R,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-16-yl]oxy]-4-hydroxy-6-(hydroxymethyl)-5-methoxyoxan-3-yl]acetamide
Preferred name
Anthenoside A
INN name
Synonym
ChEBI
CHEBI:183128

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles